Scheme 1.
Synthetic strategies (A and B) to generate linkers containing gold(I) compounds (1-4) amenable to bioconjugation to monoclonal antibodies.
Synthetic strategies (A and B) to generate linkers containing gold(I) compounds (1-4) amenable to bioconjugation to monoclonal antibodies.